201 related articles for article (PubMed ID: 32610494)
1. Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis.
Hsieh PL; Liao YW; Hsieh CW; Chen PN; Yu CC
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610494
[TBL] [Abstract][Full Text] [Related]
2. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
3. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
4. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.
Hu FW; Tsai LL; Yu CH; Chen PN; Chou MY; Yu CC
Mol Nutr Food Res; 2012 Aug; 56(8):1247-58. PubMed ID: 22692956
[TBL] [Abstract][Full Text] [Related]
5. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H
Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287
[TBL] [Abstract][Full Text] [Related]
6. Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer.
Chang WW; Hu FW; Yu CC; Wang HH; Feng HP; Lan C; Tsai LL; Chang YC
Head Neck; 2013 Mar; 35(3):413-9. PubMed ID: 22422628
[TBL] [Abstract][Full Text] [Related]
7. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Yu CH; Yu CC
PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
[TBL] [Abstract][Full Text] [Related]
9. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
11. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.
Yu D; Shin HS; Lee YS; Lee D; Kim S; Lee YC
Oncol Rep; 2014 Feb; 31(2):673-8. PubMed ID: 24297371
[TBL] [Abstract][Full Text] [Related]
12. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
Cancer Lett; 2011 Aug; 307(1):26-36. PubMed ID: 21463919
[TBL] [Abstract][Full Text] [Related]
13. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
[TBL] [Abstract][Full Text] [Related]
14. Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway.
Zhang L; Li L; Jiao M; Wu D; Wu K; Li X; Zhu G; Yang L; Wang X; Hsieh JT; He D
Cancer Lett; 2012 Oct; 323(1):48-57. PubMed ID: 22484470
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
16. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.
Xia J; Duan Q; Ahmad A; Bao B; Banerjee S; Shi Y; Ma J; Geng J; Chen Z; Rahman KM; Miele L; Sarkar FH; Wang Z
Curr Drug Targets; 2012 Dec; 13(14):1750-6. PubMed ID: 23140286
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
Ju SY; Chiou SH; Su Y
Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Wu X; Cheng YL; Matthen M; Yoon A; Schwartz GK; Bala S; Taylor AM; Momen-Heravi F
J Exp Clin Cancer Res; 2021 Feb; 40(1):70. PubMed ID: 33596979
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
20. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
